CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-25 | Lynx1 Capital Management LP 10% owner | Purchase | +259,998 | $0.56 | $147K | 8,686,953 |
| 2024-09-30 | Cale Edgar B. GC & CORPORATE SECRETARY | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-09-30 | Kassberg Thomas Richard Director | Grant or award · Employee Stock Option (right to buy) | +174,139 | 174,139 | ||
| 2024-09-19 | ORBIMED ADVISORS LLC 10% owner | Sale | −39,300 | $0.71 | $28K | 7,794,569 |
| 2024-09-18 | ORBIMED ADVISORS LLC 10% owner | Sale | −25,631 | $0.73 | $19K | 7,833,869 |
| 2024-09-17 | ORBIMED ADVISORS LLC 10% owner | Sale | −111,400 | $0.73 | $81K | 7,859,500 |
| 2024-09-16 | ORBIMED ADVISORS LLC 10% owner | Sale | −63,100 | $0.74 | $47K | 7,970,900 |
| 2024-05-21 | Countouriotis Athena Director | Grant or award · Director Stock Option (right to buy) | +47,693 | 47,693 | ||
| 2024-05-21 | GOWEN MAXINE Director | Grant or award · Director Stock Option (right to buy) | +47,693 | 47,693 | ||
| 2024-05-21 | Kapadia Sandip Director | Grant or award · Director Stock Option (right to buy) | +47,693 | 47,693 | ||
| 2024-05-21 | Islam Saqib Director | Grant or award · Director Stock Option (right to buy) | +47,693 | 47,693 | ||
| 2024-05-21 | Sondhi Dolan Director | Grant or award · Director Stock Option (right to buy) | +39,092 | 39,092 | ||
| 2024-05-21 | Porter Derrell Director | Grant or award · Director Stock Option (right to buy) | +47,693 | 47,693 | ||
| 2024-03-15 | Borthwick Kathleen CFO | Grant or award · Employee Stock Option (right to buy) | +227,000 | 227,000 | ||
| 2024-03-15 | Forman Mark S CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +203,000 | 203,000 | ||
| 2024-03-15 | Chou William PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +575,000 | 575,000 | ||
| 2024-03-15 | Cale Edgar B. GC & CORPORATE SECRETARY | Grant or award · Employee Stock Option (right to buy) | +203,000 | 203,000 | ||
| 2024-02-13 | Borthwick Kathleen SVP, INTERIM CFO | Sale | −1,470 | $0.97 | $1K | 28,466 |
| 2024-02-13 | Forman Mark S CHIEF MEDICAL OFFICER | Sale | −1,638 | $0.97 | $2K | 48,631 |
| 2024-02-10 | Borthwick Kathleen SVP, INTERIM CFO | Option exercise | +4,000 | 29,936 |
Page 4 of 8 · 152 trades